durvalumab,Tremelimumab
AstraZeneca
$azn astrazeneca shares data at easl and esmo world gi for imfinzi (durvalumab) combinations in patients with liver and biliary tract cancers #cancer
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft